Drug factory · FDA FEI 1000110954
Wyeth Pharmaceutical Division of Wyeth Holdings LLC
4300 Oak Park Rd, Sanford, NC, United States
No problems found at FDA's last inspection, Feb 28, 2011.
No Action Indicated: inspectors found no objectionable conditions.
1 drug inspection on record since 2011: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Meningococcal Groups A, B, C, W, and Y Vaccine | Makes the active ingredient and tests it | Pfizer Laboratories Div Pfizer Inc | 0069-0600 |
| Neisseria Meningitidis Group B Recombinant Lp2086 A05 Protein Variant Antigen and Neisseria Meningitidis Group B Recombinant Lp2086 B01 Protein Variant Antigen | Makes the active ingredient and tests it | Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 0005-0100 |
| Pneumococcal 20-Valent Conjugate Vaccine | Makes the active ingredient and tests it | Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 0005-2000 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 28, 2011 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; manufacture; pack.